Publisher and international news organisation NewsRx, US, has announced the launch of two newsletters on pediatrics and psychiatry/psychology. The newsletters - Pediatrics Week and Psychology & Psychiatry Journal - will cover clinical and bench research, drug development, clinical trials, business news and developments in pediatric and psychiatric medicine. The new titles are weekly newsletters, and are available in print or online at www.NewsRx.com.
Pediatrics Week provides reports on children's vaccines, new drugs approved for use in children, children's clinical trials, and childhood diseases and conditions, including cancers, autism, ADHD, and auto-immune disorders.
Psychology & Psychiatry Journal provides coverage on mental health issues, diseases and conditions, including depression, bi-polar disorders, schizophrenias, Alzheimer's and aging dementias, personality disorders, pharmacology, diagnostics and treatments.
With a portfolio of 194 titles, NewsRx claims to be one of the largest content companies in the world. Each month, over a million readers globally view and download NewsRx articles and publications online. Although the company has focused on its digital platforms, quality print content still matters, with subscribers in 25 countries.
NewsRx recently launched 86 new scientific, technical and general interest newsletters under its new division, VerticalNews. VerticalNews has titles in almost every content area, including technology, business, finance, energy, ecology, physics, chemicals, electronics, conservation, engineering, telecommunications, nanotechnology, economics, information technology, mathematics, veterinary research, agriculture and marketing. NewsRx and VerticalNews publish over 10,000 issues annually consisting of over 90,000 pages with over 500,000 articles per year.
